Sunday, December 7 , 2025 | 10:30 – 11:30 AM CDT
Chicago Marriott Downtown Magnificent Mile
Marriott Ballroom 4th Floor
Chicago, IL 60611
Game On: Where Evidence Takes the Stage
Join us for GAME-ON! | NSCLC Game Plan: Evidence-Based Strategies for HER2-Altered Care
This symposium is designed for medical oncologists caring for patients with HER2-altered non-small cell lung cancer (NSCLC). Participants will gain a deeper understanding of HER2 alterations and current tissue and liquid biopsy techniques for accurate identification. The activity highlights evolving clinical evidence to guide personalized treatment strategies and emphasizes proactive communication approaches to overcome barriers and ensure care continuity.
Put Evidence Into Action for HER2-altered NSCLC Care at this year’s IASLC & ASCO meeting
Meet Our Faculty
Eric Singhi, MD
The University of Texas MD Anderson Cancer Center
Houston, TX, USA
Martin Dietrich, MD, PhD
US Oncology Network
Orlando, FL, USA
Joshua Sabari, MD
NYU Langone Health, Perlmutter Cancer Center
New York, NY, USA
In-Person & Virtual Registration
In-Person Attendees Must Be Registered for IASLC 2025
To attend in person, you must be registered as an IASLC attendee. If you can’t join onsite, this session is also available FREE via livestream on our social channels or Zoom. Virtual participants can still earn credit, but will need to register below to receive instructions for claiming credit.
Medical oncologists who diagnose and care for patients with HER2-altered NSCLC in the United States
After completing this activity, the participant should be better able to:
Describe HER2 alterations in patients with advanced NSCLC and the current tissue and liquid biopsies for their identification.
Evaluate clinical evidence on evolving therapeutic options for NSCLC with HER2-activating mutations into individualized treatment plans.
Select pro-active strategies to facilitate communication between patients and their care team and navigate barriers to care continuity.
This activity is provided by MLI
Accreditation, Support and Credit
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
Support Statement
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.
To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education.
All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Emcee/Planner/Presenter
Eric Singhi, MD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Caris, Janssen, Lilly, Novocure, Nuvation Bio, Regeneron
Research Funding/Support: Rexanna’s Foundation for Fighting Lung Cancer
Planner/Presenter
Martin Dietrich, MD, PhD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Planner/Presenter
Joshua Sabari, MD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: AbbVie, AstraZeneca, Boehringer Ingelheim, EMD Serono, Genentech, Janssen, Jazz, Loxo Lilly, Mirati/Bristol Myers Squibb, Pfizer, Regeneron, Revolution Medicines, Sanofi Genzyme, Takeda
Research Funding/Support: Boehringer Ingelheim, Janssen J&J, Loxo Lilly, Mirati/Bristol Myers Squibb, Regeneron
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Gregory Carbonetti, PhD, has a financial interest/relationship or affiliation in the form of: Other: Artelo Biosciences (patent payment).
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity, however, registration is required. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.
About This Activity
Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.
Copyright © 2025 Medical Learning Institute Inc. All Rights Reserved.
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.